Clinical Trials at UM Baltimore Washington Medical Center/Tate Cancer Center
As of August 2026, 14 paid clinical trials are recruiting at UM Baltimore Washington Medical Center/Tate Cancer Center in Glen Burnie, Maryland. Active studies at this site cover conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8 and Colitis, Ulcerative. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
14 clinical trials at UM Baltimore Washington Medical Center/Tate Cancer Center
·Clear filters·Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Common conditions studied in Glen Burnie
- Breast Cancer (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Colitis, Ulcerative (3 active studies)
- Crohn's Disease (3 active studies)
- Glioblastoma (3 active studies)
- Ulcerative Colitis (3 active studies)
Leading research sponsors in Glen Burnie
- University of Maryland, Baltimore
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
- Takeda
Frequently asked questions
How many paid clinical trials are currently recruiting in Glen Burnie?
There are approximately 50 recruiting clinical trials in Glen Burnie, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Glen Burnie pay participants?
Most recruiting trials in Glen Burnie compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Glen Burnie?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Glen Burnie?
The most common conditions under active study in Glen Burnie include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (3), Colitis, Ulcerative (3), Crohn's Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Glen Burnie?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Glen Burnie on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Glen Burnie?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Glen Burnie?
Recruiting research sites in Glen Burnie include UM Baltimore Washington Medical Center/Tate Cancer Center, Baltimore Washington Medical Center, United Theranostics, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Glen Burnie right now?
The largest active categories in Glen Burnie are Cancer & tumors (31), Diabetes & metabolic (3), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.